Shanghai Xuerong Bio-Technology Co Ltd Net Assets
Shanghai Xuerong Bio-Technology Co Ltd net assets. Based on the latest financial reports, Shanghai Xuerong Bio-Technology Co Ltd (300511) has net assets worth CN¥1.17 Billion CNY (≈ $171.73 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.61 Billion ≈ $527.99 Million USD) and total liabilities (CN¥2.43 Billion ≈ $356.26 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Shanghai Xuerong Bio-Technology Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.17 Billion |
| % of Total Assets | 32.53% |
| Annual Growth Rate | 6.63% |
| 5-Year Change | -59.3% |
| 10-Year Change | 28.05% |
| Growth Volatility | 32.54 |
Net Assets of Shanghai Xuerong Bio-Technology Co Ltd (2012–2024)
Net assets of Shanghai Xuerong Bio-Technology Co Ltd from 2012 to 2024. This chart illustrates how Shanghai Xuerong Bio-Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. See how leveraged is Shanghai Xuerong Bio-Technology Co Ltd's balance sheet to measure how much of total assets are equity-financed.
Annual Net Assets for Shanghai Xuerong Bio-Technology Co Ltd (2012–2024)
The table below shows the annual net assets of Shanghai Xuerong Bio-Technology Co Ltd from 2012 to 2024. For live market cap and overall valuation, see 300511 market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥823.32 Million ≈ $120.48 Million |
-42.52% |
| 2023-12-31 | CN¥1.43 Billion ≈ $209.60 Million |
-11.90% |
| 2022-12-31 | CN¥1.63 Billion ≈ $237.91 Million |
-1.74% |
| 2021-12-31 | CN¥1.65 Billion ≈ $242.11 Million |
-18.21% |
| 2020-12-31 | CN¥2.02 Billion ≈ $296.00 Million |
+16.26% |
| 2019-12-31 | CN¥1.74 Billion ≈ $254.60 Million |
+10.82% |
| 2018-12-31 | CN¥1.57 Billion ≈ $229.73 Million |
+10.84% |
| 2017-12-31 | CN¥1.42 Billion ≈ $207.26 Million |
+9.81% |
| 2016-12-31 | CN¥1.29 Billion ≈ $188.75 Million |
+100.60% |
| 2015-12-31 | CN¥642.99 Million ≈ $94.09 Million |
+21.55% |
| 2014-12-31 | CN¥529.00 Million ≈ $77.41 Million |
+22.03% |
| 2013-12-31 | CN¥433.49 Million ≈ $63.43 Million |
+13.73% |
| 2012-12-31 | CN¥381.15 Million ≈ $55.77 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shanghai Xuerong Bio-Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 395.6% over the analyzed period, potentially due to dividend distributions or operating losses.
Shanghai Xuerong Bio-Technology Co Ltd Net Assets Breakdown (December 2024)
Shanghai Xuerong Bio-Technology Co Ltd net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CN¥1.40 Billion | 149.51% |
| Total Equity | CN¥938.63 Million | 100.00% |
Shanghai Xuerong Bio-Technology Co Ltd Competitors by Market Cap
The table below lists competitors of Shanghai Xuerong Bio-Technology Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
STL Technology Co Ltd
TWO:4931
|
$376.99 Million |
|
Guangdong Jinming Machinery Co Ltd
SHE:300281
|
$377.01 Million |
|
Sysgration Ltd
TWO:5309
|
$377.13 Million |
|
China Datang Corporation Renewable Power Co. Limited
STU:DT7
|
$377.20 Million |
|
ZheJiang Haers Vacuum Containers Co Ltd
SHE:002615
|
$376.63 Million |
|
Autolus Therapeutics Ltd
NASDAQ:AUTL
|
$376.62 Million |
|
Ideal United Bintang Bhd
KLSE:9687
|
$376.60 Million |
|
Gazit Globe Ltd
TA:GZT
|
$376.58 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shanghai Xuerong Bio-Technology Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,554,529,572 to 938,628,712, a change of -615,900,860 (-39.6%).
- Net loss of 617,070,813 reduced equity.
- Dividend payments of 67,006,895 reduced retained earnings.
- Other factors increased equity by 68,176,848.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-617.07 Million | -65.74% |
| Dividends Paid | CN¥67.01 Million | -7.14% |
| Other Changes | CN¥68.18 Million | +7.26% |
| Total Change | CN¥- | -39.62% |
Book Value vs Market Value Analysis
This analysis compares Shanghai Xuerong Bio-Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.14x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.26x to 2.14x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CN¥3.19 | CN¥4.02 | x |
| 2018-12-31 | CN¥3.61 | CN¥4.02 | x |
| 2019-12-31 | CN¥4.05 | CN¥4.02 | x |
| 2020-12-31 | CN¥4.60 | CN¥4.02 | x |
| 2021-12-31 | CN¥3.78 | CN¥4.02 | x |
| 2022-12-31 | CN¥3.47 | CN¥4.02 | x |
| 2023-12-31 | CN¥3.12 | CN¥4.02 | x |
| 2024-12-31 | CN¥1.88 | CN¥4.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shanghai Xuerong Bio-Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -65.74%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -28.54%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 4.11x
- Recent ROE (-65.74%) is below the historical average (-4.19%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 19.43% | 12.10% | 0.57x | 2.80x | CN¥59.86 Million |
| 2016 | 8.17% | 10.49% | 0.41x | 1.92x | CN¥-23.42 Million |
| 2017 | 8.82% | 9.20% | 0.35x | 2.77x | CN¥-16.31 Million |
| 2018 | 9.65% | 8.20% | 0.47x | 2.48x | CN¥-5.43 Million |
| 2019 | 12.66% | 11.22% | 0.51x | 2.21x | CN¥46.28 Million |
| 2020 | 12.16% | 11.23% | 0.48x | 2.24x | CN¥43.84 Million |
| 2021 | -18.47% | -14.97% | 0.48x | 2.60x | CN¥-476.11 Million |
| 2022 | -16.48% | -12.38% | 0.57x | 2.34x | CN¥-461.55 Million |
| 2023 | -12.10% | -7.33% | 0.56x | 2.96x | CN¥-343.52 Million |
| 2024 | -65.74% | -28.54% | 0.56x | 4.11x | CN¥-710.93 Million |
Industry Comparison
This section compares Shanghai Xuerong Bio-Technology Co Ltd's net assets metrics with peer companies in the Farm Products industry.
Industry Context
- Industry: Farm Products
- Average net assets among peers: $6,292,336,370
- Average return on equity (ROE) among peers: -2.07%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shanghai Xuerong Bio-Technology Co Ltd (300511) | CN¥1.17 Billion | 19.43% | 2.07x | $376.98 Million |
| ShenZhen Kondarl Group Co Ltd (000048) | $4.14 Billion | 3.69% | 1.44x | $1.05 Billion |
| Guangdong Guanghong Holdings Co Ltd (000529) | $3.33 Billion | 3.69% | 1.07x | $391.26 Million |
| Hunan Zhenghong Science and Technology Develop Co Ltd (000702) | $330.96 Million | -42.26% | 1.17x | $250.06 Million |
| Hefei Fengle Seed Co Ltd (000713) | $1.34 Billion | 4.53% | 0.40x | $626.07 Million |
| Luoniushan Co Ltd (000735) | $4.42 Billion | -11.03% | 1.75x | $852.62 Million |
| New Hope Liuhe Co Ltd (000876) | $35.93 Billion | 0.69% | 2.61x | $4.65 Billion |
| Yuan Longping High-tech Agriculture Co Ltd (000998) | $10.13 Billion | 1.98% | 1.74x | $1.72 Billion |
| Dongrui Food Group Co Ltd (001201) | $140.85 Million | -19.04% | 1.66x | $580.54 Million |
| Jiangxi Sunshine Dairy Co Ltd (001318) | $565.47 Million | 24.00% | 0.31x | $655.17 Million |
| Shandong Denghai Seeds Co Ltd (002041) | $2.59 Billion | 13.02% | 0.35x | $1.10 Billion |
About Shanghai Xuerong Bio-Technology Co Ltd
Shanghai Xuerong Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research and development, cultivation and sale of fresh edible mushrooms in the People's Republic of China. It offers enoki mushrooms; shiitake mushrooms, including oyster mushrooms, white jade mushrooms and seafood mushrooms; king oyster mushrooms; and velvet mushrooms, as well as Pleurotus eryngii and Flammu… Read more